CLINICAL_TRIALS trial_result · 2023-10-27

Clinical Trial Update: Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer [Phase 2]

Phase II study assessing chemo-radiotherapy for resectable and borderline resectable pancreatic cancer; trial completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Henry Ford Health System | Conditions: Pancreas Neoplasm Malignant Resectable | Phase 2 | Status: COMPLETED | Results posted: 2023-10-27